Letter by Millis et al Regarding Article, “Safety of Switching From a Vitamin K Antagonist to a Non–Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”
Circulation · 2024
DOI: 10.1161/circulationaha.123.067571 ↗Kurz gefasst
Leserbrief in der Zeitschrift Circulation, 2024. Verfasst von Christopher E Millis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine (C.E.M.), University of South Florida Morsani College of Medicine, Tampa. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants, Vitamin K, Frail Elderly. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine (C.E.M.), University of South Florida Morsani College of Medicine, Tampa.
- Division of Cardiovascular Sciences (D.F.F., X.E.P.), University of South Florida Morsani College of Medicine, Tampa.
ORCID-Profile: Christopher E Millis
Zitieren
APA
Millis, C. E., Feradov, D. F., & Prida, X. E. (2024). Letter by Millis et al Regarding Article, “Safety of Switching From a Vitamin K Antagonist to a Non–Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”. Circulation. https://doi.org/10.1161/circulationaha.123.067571
Vancouver
Millis CE, Feradov DF, Prida XE. Letter by Millis et al Regarding Article, “Safety of Switching From a Vitamin K Antagonist to a Non–Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”. Circulation. 2024. doi:10.1161/circulationaha.123.067571
BibTeX
@article{Millis2024,
author = {Millis, Christopher E and Feradov, Denise F and Prida, Xavier E},
title = {Letter by Millis et al Regarding Article, “Safety of Switching From a Vitamin K Antagonist to a Non–Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”},
journal = {Circulation},
year = {2024},
doi = {10.1161/circulationaha.123.067571}
}
EUVIMED